Cargando…
Evaluation of a Novel Immunoassay for Quantification of C1q for Clinical Diagnostic Use
Objectives: C1q is a valuable biomarker of disease activity in systemic lupus erythematosus (SLE). The “gold standard” assay, rocket immunoelectrophoresis (RIE), is time-consuming, and thus a shift to soluble immune precipitation techniques such as nephelometry has occurred. However, quantification...
Autores principales: | Sandholm, Kerstin, Persson, Barbro, Skattum, Lillemor, Eggertsen, Gösta, Nyman, Dag, Gunnarsson, Iva, Svenungson, Elisabet, Nilsson, Bo, Ekdahl, Kristina N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6357986/ https://www.ncbi.nlm.nih.gov/pubmed/30740097 http://dx.doi.org/10.3389/fimmu.2019.00007 |
Ejemplares similares
-
Interpretation of Serological Complement Biomarkers in Disease
por: Ekdahl, Kristina N., et al.
Publicado: (2018) -
Current and Future Approaches for Monitoring Responses to Anti-complement Therapeutics
por: Mohebnasab, Maedeh, et al.
Publicado: (2019) -
Comorbidities in hereditary angioedema—A population‐based cohort study
por: Sundler Björkman, Linda, et al.
Publicado: (2022) -
Complement activation in individuals with previous subclinical Lyme borreliosis and patients with previous Lyme neuroborreliosis
por: Carlsson, Hanna, et al.
Publicado: (2019) -
How COVID-19 and other pathological conditions and medical treatments activate our intravascular innate immune system
por: Nilsson, Bo, et al.
Publicado: (2023)